Vault-13

Aquilo Capital Management, LLC

SAN FRANCISCO, CA · CIK 1591986 · 13F filing filed 2020-02-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$147.3m reported value
11positions
99.9%in top 10
—no comparable previous quarter

Options: 0 call positions (— notional), 1 put positions ($118.9m notional) – listed below, not included above.

Holdings, Q4 2019

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 UNIQURE NV SHS QURE QURE 396,899 $28.4m19.30% 19.30% —
2 PROQR THRAPEUTICS N V SHS EURO PRQR PRQR 1,922,570 $19.1m12.93% 12.93% —
3 PIERIS PHARMACEUTICALS INC COM COM 4,966,820 $17.8m12.06% 12.06% —
4 XENON PHARMACEUTICALS INC COM XENE XENE 1,166,736 $15.3m10.38% 10.38% —
5 GALAPAGOS NV SPON ADR LKFT LKFT 71,967 $14.9m10.10% 10.10% —
6 MERUS N V COM MRUS MRUS 1,038,746 $14.6m9.93% 9.93% —
7 DICERNA PHARMACEUTICALS INC COM DRNA DRNA 614,436 $13.5m9.19% 9.19% —
8 SPERO THERAPEUTICS INC COM SPRO SPRO 1,154,356 $11.1m7.53% 7.53% —
9 REGENXBIO INC COM RGNX RGNX 268,778 $11.0m7.47% 7.47% —
10 FATE THERAPEUTICS INC COM FATE FATE 72,273 $1.4m0.96% 0.96% —
11 MORPHOSYS AG SPONSORED ADS SPONSORED ADS 6,080 $217.0k0.15% 0.15% —

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
SPDR SER TR XBI · Put XBIPut 1,250,000 $118.9m1.2m shares —